Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The LION Study is a prospective, single-center phase 1 clinical trial to evaluate the safety,
tolerability, and distribution of Laquinimod administered as topical eye drops for two weeks
in human participants.